Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS).

PubWeight™: 1.77‹?› | Rank: Top 3%

🔗 View Article (PMC 2737546)

Published in Circulation on September 15, 2008

Authors

Tatjana Rundek1, Mitchell S V Elkind, Marco R Di Tullio, Emmanuel Carrera, Zhezhen Jin, Ralph L Sacco, Shunichi Homma

Author Affiliations

1: Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA. trundek@med.miami.edu

Articles citing this

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Sensitivity of transcranial Doppler versus intracardiac echocardiography in the detection of right-to-left shunt. JACC Cardiovasc Imaging (2010) 1.71

Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations. Nat Rev Neurosci (2014) 1.20

Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol (2010) 1.15

Comorbidities of migraine. Front Neurol (2010) 1.05

Spreading Depression, Spreading Depolarizations, and the Cerebral Vasculature. Physiol Rev (2015) 0.99

Emerging risk factors for cardiovascular diseases: Indian context. Indian J Endocrinol Metab (2013) 0.97

Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies. Neuroepidemiology (2012) 0.90

Migraine, white matter hyperintensities, and subclinical brain infarction in a diverse community: the northern Manhattan study. Stroke (2014) 0.87

Migraine and stroke: "vascular" comorbidity. Front Neurol (2014) 0.87

The Migraine-Stroke Connection. J Stroke (2016) 0.82

Association between variations in coagulation system genes and carotid plaque. J Neurol Sci (2012) 0.81

Migraine and risk of stroke in older adults: Northern Manhattan Study. Neurology (2015) 0.79

Prevalence of cardiac right left shunts in migraine: a population-based case-control study. Neurol Sci (2012) 0.79

Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol (2016) 0.78

Systemic right-to-left shunts, ischemic brain lesions, and persistent migraine activity. Neurology (2016) 0.77

Migraine headaches following catheter ablation for atrial fibrillation. J Interv Card Electrophysiol (2010) 0.77

Migraine with aura and patent foramen ovale: myth or reality? Neurol Sci (2015) 0.76

How to Understand Patent Foramen Ovale Clinical Significance: Part I. J Cardiovasc Echogr (2017) 0.75

Migraine: a matter of the heart? Circulation (2008) 0.75

Strong association between right-to-left shunt and migraine. Neth Heart J (2010) 0.75

Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study. J Am Heart Assoc (2016) 0.75

Coincidental Impact of Transcatheter Patent Foramen Ovale Closure on Migraine with and without Aura - A Comprehensive Meta-Analysis. Clin Trials Regul Sci Cardiol (2016) 0.75

Migraine and stroke. Stroke Vasc Neurol (2017) 0.75

Articles cited by this

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia (1988) 14.61

Migraine--current understanding and treatment. N Engl J Med (2002) 9.80

Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc (1984) 9.00

The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data. Am J Prev Med (1988) 7.67

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation (2002) 4.69

Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08

Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation (2008) 3.47

The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J (2005) 3.06

Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke (2005) 2.86

Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80

Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke (2004) 2.76

Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke (1998) 2.70

The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology (1999) 2.69

The global burden of disease study: implications for neurology. Arch Neurol (2000) 2.44

Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology (1999) 2.44

Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache (2007) 2.18

Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol (2007) 2.15

Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology (2004) 2.09

Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet (2000) 1.99

Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart (2004) 1.68

Age-dependent prevalence and clinical features of migraine. Neurology (2006) 1.61

Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis (1998) 1.58

Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol (2005) 1.40

Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke (1993) 1.39

Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology (2004) 1.32

Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology (2005) 1.24

Patent foramen ovale and migraine. Curr Pain Headache Rep (2007) 1.17

Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia (2006) 1.14

Patent foramen ovale and migraine--bringing closure to the subject. Headache (2006) 1.10

Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain (2005) 1.06

Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart (2005) 1.01

The pathophysiology of migraine: year 2005. J Headache Pain (2005) 0.98

High prevalence of patent foramen ovale in migraine with aura. J Headache Pain (2005) 0.96

Migraine with aura related to closure of atrial septal defects. Headache (2005) 0.79

Articles by these authors

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke (2010) 10.66

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation (2002) 9.04

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 8.30

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25

Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke (2009) 6.62

Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 5.04

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation (2002) 4.69

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation (2011) 4.65

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation (2014) 4.56

Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51

Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med (2012) 3.50

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation (2014) 3.28

Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation (2005) 3.25

Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke (2008) 3.21

Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14

The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89

Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res (2008) 2.88

Continuous electroencephalography in the medical intensive care unit. Crit Care Med (2009) 2.86

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation (2006) 2.86

National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82

Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2005) 2.75

Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66

Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57

Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56

Diagnostic accuracy of noncontrast computed tomography for appendicitis in adults: a systematic review. Ann Emerg Med (2009) 2.55

Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke (2007) 2.55

Early EEG correlates of neuronal injury after brain anoxia. Neurology (2012) 2.53

Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke (2005) 2.51

Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48

AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol (2011) 2.45

Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke (2003) 2.45

2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44

Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 2.43

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2006) 2.42

Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40

Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest (2003) 2.39

Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38

Stroke in the young in the northern Manhattan stroke study. Stroke (2002) 2.37

Patent foramen ovale and stroke. Circulation (2005) 2.34

Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34

Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol (2005) 2.34

Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33

Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30

An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26

Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J Clin Invest (2007) 2.23

Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke (2011) 2.19

Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail (2011) 2.19

Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17

Left ventricular mass and geometry and the risk of ischemic stroke. Stroke (2003) 2.15

Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol (2007) 2.15

Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc Natl Acad Sci U S A (2011) 2.14

Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13

Reliability of the blood flow velocity pulsatility index for assessment of intracranial and cerebral perfusion pressures in head-injured patients. Neurosurgery (2012) 2.12

Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke (2006) 2.09

Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol (2009) 2.08

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol (2008) 2.07

Direct measurement of multiple vena contracta areas for assessing the severity of mitral regurgitation using 3D TEE. JACC Cardiovasc Imaging (2012) 2.06

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06

Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke (2002) 2.06

Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke (2006) 2.05

Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00

Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97

Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke (2007) 1.96